Navigation Links
University Hospitals Seidman Cancer Center Opens: First Cancer Hospital in Northeast Ohio Offers Nation's Most Advanced Technology and Treatments
Date:6/6/2011

CLEVELAND, June 6, 2011 /PRNewswire/ -- University Hospitals (UH) Seidman Cancer Center, Northeast Ohio's first and only freestanding cancer hospital, opens to patients on June 6. The ten-story, 150-bed cancer hospital will house the latest cancer-fighting treatments and technology – all in a patient-centered, healing-focused environment.

(Photo:  http://photos.prnewswire.com/prnh/20110606/CL13806 )

The $260 million, 375,000-square-foot hospital is named for Jane and Lee Seidman in honor of their $42 million gift to UH in November 2010. One of 12 freestanding cancer hospitals in the country that are part of a National Cancer Institute-designated Comprehensive Cancer Center, the UH Seidman Cancer Center consolidates all inpatient and outpatient cancer services on the UH Case Medical Center campus in Cleveland's University Circle.

"The Seidman Cancer Center will truly transform cancer care in Northeast Ohio and beyond," says Nathan Levitan, MD, President of the UH Seidman Cancer Center. "This state-of-the-art hospital brings a wealth of diagnostic and treatment technologies under one roof to provide the nation's most advanced cancer care."

Highlights of the technologically advanced UH Seidman Cancer Center include:

  • Comprehensive imaging technology, including a hybrid PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging), one of four in the world, which will generate enhanced digital images to pinpoint precise tumor locations.
  • Operating room with 3 Tesla intra-operative MRI suite which enables surgeons to obtain real-time images during procedures to reduce the need for re-operation.
  • More than 300 clinical trials offering patients access to the latest treatments first.
  • Radiation Oncology Center provides a full array of cutting-edge radiation therapy technologies.
  • Outpatient clini
    '/>"/>

SOURCE University Hospitals Seidman Cancer Center
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. University of Pennsylvania Announces Partnership with Chinese Academy of Sciences for Center of Excellence in Brain Mapping
2. University Hospitals Seidman Cancer Center Announces $30 Million Proton Therapy Center
3. Hackensack University Medical Center Employs Built-To-Last Automated Storage by Talyst
4. Prime Therapeutics President and CEO Eric Elliott Delivers Speech at University of Minnesota College of Pharmacy Dialogues in Managed Care Leadership 2011
5. Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
6. BIOCOM Response to Health Portion of Presidents Speech at George Washington University
7. General Dynamics InForce™ Training Toolkit to Support Vincennes University Hospital Simulation Lab
8. Mtech Announces Finalists for University of Maryland $75K Business Plan Competition
9. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
10. $2 Million Awarded to Duke University Prevention Epicenter to Study Reduction of Healthcare-Associated Infections Using Tru-D, Total Room Ultraviolet Disinfection
11. Sanofi-aventis Enters Into Research Collaboration With Columbia University to Develop New Diabetes Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
(Date:9/5/2015)... ... ... If you are nervous about either giving or getting shots, you are ... than ever before for an idea conceived of by an inventor from Cerritos, Calif. ... and patients against accidental needle punctures. As such, it prevents surgical team members from ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... elderly Americans currently being cared for in nursing homes and assisted living facilities are ... discussed a personal story in which her father was at one point close to ...
(Date:9/4/2015)... Viejo, CA (PRWEB) , ... September 04, 2015 , ... ... click of a mouse all within Final Cut Pro X. With TransCel users have ... Adjust the frame width, background color, speed method, frame color, inner color, text, and ...
(Date:9/4/2015)... , ... September 04, 2015 , ... IVF New England, ... a New Hampshire fertility "ManchVegas Happy Hour" in Manchester for women who wish to ... 2015 at XO on Elm restaurant and lounge, 827 Elm Street, Manchester, NH from ...
(Date:9/4/2015)... ... September 04, 2015 , ... A Union County charitable ... Core Compassion Project is a non-profit organization dedicated to offering Pilates scholarships to ... cancer treatments and recover their mobility, strength, and range of motion following breast ...
Breaking Medicine News(10 mins):Health News:Safety Feature for Needle Injections Invented by InventHelp Client (OCM-914) 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2
... the European Society for Clinical and Economic Aspects ... partnership to develop a unique springtime meeting programme ... over 5,500 participants, this has become the largest ... for osteoporosis and osteoarthritis in Europe. The ...
... , MONDAY, Oct. 31 (HealthDay News) -- Teens who ... more likely to fight, carry a weapon and join a gang, ... more than 10,000 public school students in grades 8, 10 and ... Survey. Among eighth-graders, boys with a parent on military deployment ...
... A new study describes a 2010 outbreak involving ... a norovirus outbreak in a professional sports association. ... available online ( http://www.oxfordjournals.org/our_journals/cid/prpaper.pdf ), the study highlights ... among players and staff on and off the ...
... impairment is Fragile X Syndrome, caused by mutation or malfunction ... the most common genetic cause of autism. Understanding how this ... Fragile X patients and others. Researchers from the ... colleagues from Brown University, have identified the FMRP protein (encoded ...
... By Dennis Thompson HealthDay Reporter , FRIDAY, Oct. ... that make vision dull and yellowed. Shoes that throw the ... Gloves that make fingers clumsy and awkward. These are ... Institute of Technology to help product designers prepare the world ...
... News) -- Headaches are a leading reason for medical ... for the falling number of active-duty troops in those ... one of the top three causes of non-combat-related loss ... Afghanistan, and headaches are the most common neurological problem, ...
Cached Medicine News:Health News:Attend the premier bone meeting in Europe 2Health News:Teens With a Deployed Parent May Be More Prone to Violence 2Health News:NBA players not immune to serious illness from norovirus 2Health News:Linking Fragile X Syndrome proteins and RNA editing mistakes at nerve-muscle junction 2Health News:Linking Fragile X Syndrome proteins and RNA editing mistakes at nerve-muscle junction 3Health News:High-Tech Suit Lets You Know What It's Like to Be Old 2Health News:High-Tech Suit Lets You Know What It's Like to Be Old 3Health News:Headaches Take Soldiers Away From War 2
Anti-Gliadin IgG (Ab) EIA Gastrointestinal Markers 027-GD16 Celiac Disease Food Allergy...
... Vitamin D kit is an enzymeimmunoassay for ... hydroxylated metabolites in serum or plasma. Calibrators, ... labelled 25-OH D. The diluted samples are ... with a highly specific sheep 25-OH D ...
EPO EIA Human Cytokines 021-SDX021 Erythropoietin Anemia...
... Immunoscan Anti-GBM was developed to detect ... glomerular basement membrane. The information is ... where anti-collagen (IV) - a3 chain ... pulmonary hemorrhage are primary diagnostic parameters. ...
Medicine Products: